Chloroquine-resistant <it>Plasmodium vivax </it>malaria in Debre Zeit, Ethiopia
<p>Abstract</p> <p>Background</p> <p><it>Plasmodium vivax </it>accounts for about 40% of all malaria infection in Ethiopia. Chloroquine (CQ) is the first line treatment for confirmed <it>P. vivax </it>malaria in the country. The first report of C...
| Príomhchruthaitheoirí: | , , , , , , , , |
|---|---|
| Formáid: | Alt |
| Teanga: | English |
| Foilsithe / Cruthaithe: |
BMC
2008-10-01
|
| Sraith: | Malaria Journal |
| Rochtain ar líne: | http://www.malariajournal.com/content/7/1/220 |